U.S. Machinery Stock News

Helmerich & Payne (HP) drew fresh attention after reporting fiscal Q3 2026 results that came in above its own guidance, along with a higher full-year North America rig-count outlook and a continued focus on debt reduction. See our latest analysis for Helmerich & Payne. At a share price of $37.10, Helmerich & Payne has seen a 30 day share price return of 11.31% and a year to date share price return of 23.91%, while the 1 year total shareholder return of 122.62% contrasts with a modest 3 year...

Carlisle Companies dividend hike and guidance raise put capital returns in focus Carlisle Companies (CSL) has drawn fresh attention after reporting record second quarter results, raising full year revenue guidance to mid single digit growth and lifting its 2026 share repurchase target to $1.2b. At the same time, the Board approved a 14% increase in the regular quarterly dividend to $1.25 per share, or $5 on an annualized basis. The dividend is payable on September 1, 2026, to shareholders of...

Why QuinStreet’s latest earnings and M&A comments matter for investors QuinStreet (QNST) has put itself firmly on investors’ radars after reporting detailed fourth quarter and full year 2026 results, alongside new fiscal 2027 revenue guidance and fresh commentary on potential acquisitions. The company reported fourth quarter sales of US$373.88 million and net income of US$19.11 million. For the full 2026 fiscal year, sales were US$1.29b with net income of US$81.24 million, according to the...

AtriCure (ATRC) has drawn investor attention after multiple insider share sales. This followed a quarter in which the company reported 13% second quarter revenue growth, a return to net income, and raised full year guidance. See our latest analysis for AtriCure. AtriCure’s recent insider sales come against a backdrop of strong share price momentum, with a 57.38% 90 day share price return and 20.74% 30 day share price return, while the 5 year total shareholder return is still down 43.49%. If...

GH Research PLC recently reported second-quarter 2026 results showing a net loss of US$15.15 million, up from US$9.29 million a year earlier, with basic and diluted loss per share from continuing operations rising to US$0.23 from US$0.15. For the first half of 2026, the company’s net loss expanded to US$34.11 million versus US$20.10 million in the prior-year period, highlighting a meaningful increase in cash burn and pressure on its financial profile. We’ll now examine how this widening net...

Pediatrix Medical Group has delivered a strong 89.0% share price return over the past year, yet the stock still screens as cheap on several valuation checks. This raises the question of how much of the recent improvement is already reflected in the price. The recent share price drop following earnings news adds another layer for investors weighing whether the current level still offers value. Over the last 1 year, Pediatrix Medical Group shares are up 89.0%. This means anyone looking at the...

Axsome Therapeutics event context and recent stock performance Axsome Therapeutics (AXSM) continues to draw investor attention as it advances therapies for central nervous system disorders, including approved treatments for depression, excessive daytime sleepiness, and migraine, alongside multiple late stage clinical programs. The stock last closed at US$212.74 on 7 August 2026. Over the past month the share price declined 9%, while the past 3 months show a smaller fall of 1.7%, leaving the...

Expro (XPRO) updated investors with higher full year 2026 revenue guidance and fresh quarterly targets, following softer second quarter results and a completed share buyback that reduced the share count by 2.2%. See our latest analysis for Expro. The guidance update and buyback arrive after a mixed stretch for Expro, with a 24.34% year to date share price return and a 64.98% total shareholder return over one year, but a 26.93% total shareholder return decline over three years. Recent 7 day...

What the latest earnings mean for Organogenesis Holdings stock Organogenesis Holdings (ORGO) is back in focus after second quarter results showed sharply lower revenue and a much wider net loss, alongside a deeper revenue outlook cut and a planned US$75 million equity raise. The earnings update matters for you because it reshapes expectations on cash generation, dilution risk and how much flexibility Organogenesis Holdings might have to fund its wound care portfolio, including products like...

Weaker US job numbers, softer wage growth, and fading odds of a September Fed hike have put major bank stocks under a sharper spotlight. When the labor market cools and rate expectations shift, the ripple effects can matter for profits, loan quality, and investor confidence. This article walks through three large US bank stocks that appear especially exposed to this latest data, and explains why that may give you a reason to reassess your own banking exposure today. Wells Fargo...

Why the new First Plus mandate matters for SS&C Technologies SS&C Technologies Holdings (SSNC) has been selected by First Plus Asset Management Pte. Ltd. to support around US$200 million in cross-border assets across Asia, covering transfer agency, order management, execution, and investment accounting. This new client adds to SS&C Technologies Holdings' global operations footprint and gives investors fresh information about how its integrated service model is being used across multiple Asian...

Joby Aviation (JOBY) is back in focus after a busy week, with the stock reacting to raised 2026 revenue guidance, a new 45,000 square foot Texas facility, and a fresh vertiport partnership with Atoms. See our latest analysis for Joby Aviation. The latest facility opening and vertiport partnership have come alongside a 7 day share price return of 20.84% and a 1 day move of 4.98%. However, Joby Aviation’s year to date share price return is still down 39.83% and the 1 year total shareholder...

Crescent Energy Company recently reported past second-quarter 2026 results, with revenue rising to US$1,394.95 million and net income to US$492.77 million, alongside higher basic and diluted earnings per share from continuing operations compared with a year earlier. However, for the first half of 2026, revenue increased to US$2,577.78 million while net income and earnings per share from continuing operations were lower than the prior-year period, highlighting a sharp contrast between...

Insight Enterprises stock has gained 77.8% year to date, and current valuation checks suggest the market price still sits below an intrinsic value estimate based on a Discounted Cash Flow (DCF), with earnings multiples telling a similar story. Year to date, Insight Enterprises is up 77.8%, which puts extra focus on whether recent gains already reflect the company’s long term cash flow potential. Future revenue and cash flow growth can support the current share price, while any pressure on...

Adams Diversified Equity Fund, Inc. has reported past-half‑year earnings for the period ended June 30, 2026, posting revenue of US$18.94 million and net income of US$320.68 million. The large gap between revenue and net income draws attention to how factors beyond core fee income may have influenced overall profitability. We will now explore how the strong net income reported for the half year shapes Adams Diversified Equity Fund’s investment narrative. Uncover the next big thing with 20...

Bowhead Specialty Holdings earnings and buyout agreement set the scene Bowhead Specialty Holdings (BOW) just reported second quarter 2026 results, alongside news that American Family Mutual Insurance Company agreed to acquire the remaining 84.8% stake for US$34.00 per share in cash. See our latest analysis for Bowhead Specialty Holdings. Bowhead Specialty Holdings’ share price has moved to US$33.45, with a 7 day share price return of 9.35% and a 90 day share price return of 20.02%. The 1 year...

Zymeworks Inc. has reported second-quarter 2026 results showing a net loss of US$45.02 million, compared with net income of US$2.32 million a year earlier, while basic and diluted loss per share from continuing operations widened to US$0.62 from earnings per share of US$0.03. For the first half of 2026, the company’s net loss rose to US$89.18 million from US$20.32 million in the prior-year period, highlighting significantly higher losses that may raise fresh questions about how its...

Why UPS raised its outlook and refreshed its digital tools United Parcel Service (UPS) recently raised its consolidated earnings guidance for 2026 and rolled out new digital shipping tools for small and medium sized businesses, putting both profitability goals and customer experience in focus for investors. See our latest analysis for United Parcel Service. United Parcel Service shares trade at US$104.50 after a 4.5% 90 day share price return and a 3.4% year to date share price gain. The 1...

In recent days, Bitmine Immersion Technologies has attracted fresh attention as investors reassess its cryptocurrency-focused operations against measures such as book value and discounted cash flow estimates. This renewed scrutiny highlights how reliance on cryptocurrency mining revenue and ongoing net losses can create tension between different ways of judging the company’s worth. With these issues in focus, we’ll now examine how concerns around its cryptocurrency-dependent business model...

TIC Solutions (TIC) drew fresh attention on 6 August 2026 after reaffirming full year revenue guidance of US$2,150 million to US$2,250 million and reporting second quarter results that combined higher sales with continued net losses. See our latest analysis for TIC Solutions. The reaffirmed guidance and second quarter update appear to have sharpened investor focus on TIC Solutions, with a 1 day share price return of 15.9% and a 7 day share price return of 37.6% lifting the share price to...

Immunocore Holdings (IMCR) just reported second quarter 2026 earnings, with revenue of US$115.93 million and a reduced net loss of US$0.81 million, alongside updated five year survival data for KIMMTRAK. See our latest analysis for Immunocore Holdings. Immunocore Holdings’ latest earnings update and KIMMTRAK survival data come after a steady build in momentum, with a 30 day share price return of 6.42% and a 90 day share price return of 17.85%. However, the 3 year total shareholder return...

Hewlett Packard Enterprise (HPE) is back in focus after Rigetti Computing and Pittsburgh Supercomputing Center selected the company to help build the TangleLab supercomputing testbed funded by a US$5 million National Science Foundation grant. See our latest analysis for Hewlett Packard Enterprise. Against that backdrop, Hewlett Packard Enterprise’s recent announcements in high performance and quantum computing arrive during a period of strong momentum, with a 90 day share price return of...

Regulators are turning up the heat on false discounts, subscription traps and opaque pricing, and that puts a fresh spotlight on companies that help retailers stay on the right side of consumer protection rules. This shift creates potential winners among compliance and retail technology specialists, as demand for transparent pricing and subscription management tools grows. This article reveals 3 stocks tied to these changes and explains how the news connects to each one. The three stocks in...

MINISO Group Holding (MNSO) has opened its first pop-up store in Kraków’s Galeria Krakowska, marking the company’s debut in southern Poland. This temporary store highlights MINISO’s expanding European footprint and evolving retail formats. See our latest analysis for MINISO Group Holding. MINISO Group Holding’s latest European pop up comes at a time when momentum in the stock has softened. The share price is US$12.55 and the year to date share price return is down 35.61%, while the 1 year...